Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

Biotechnology

Healthcare
$7.38 -2.78%

-$0.15 today

Market cap
$2.10B
Beta
0.71
P/E (TTM)
-7.1
EPS (TTM)
-$0.71
52W Low $1.99High $5.32

Volume 1.41M

Average 2.42M

MRVI Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

Maravai LifeSciences Holdings, Inc.NASDAQ: MRVI

Accumulated OCI · Q2 FY2026 · quarter ended Jun 2026

Accumulated OCI falls 20.0% from a year ago

Accumulated OCI stood at $459K at the end of Q2 FY2026, down 20.0% from a year earlier and down 1.5% from the prior quarter.

Context

  • Accumulated OCI amounted to 0.1% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Accumulated OCI increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -20.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$459K-1.5% QoQ
Last fiscal yearDec 2025
$524K— YoY
Year agoJun 2025
$574K-20.0% since
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-20.0%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
524K USD
Year-over-year change
—

Accumulated OCI vs competitors

How MRVI compares with its peers on the latest reported figures

  • MRVI's Jun 2026 Accumulated OCI of $459K is the highest of the 9 companies compared; the peer median is -$16.04M.
  • Its year-over-year change of -20.0% is the 3rd highest of 9, against a peer median of -141.1%.
  • Accumulated OCI amounts to 0.1% of total assets for MRVI, versus a peer median of 0.5%.
MRVI Competitors Peer median
Accumulated OCI for MRVI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MRVIMaravai LifeSciences Holdings, Inc.Jun 2026$459K -20.0%—0.1%
BLFSBioLife Solutions, Inc.Mar 2026-$120K -463.6%—0.0%
PACBPacific Biosciences of California, Inc.Mar 2026-$147K -138.6%—0.0%
LABStandard BioTools Inc.Mar 2026-$511K -143.7%—0.1%
NEOGNeogen CorporationAug 2026-$12.3M +47.6%—0.4%
RGENRepligen CorporationJun 2026-$19.79M -1053.0%—0.7%
TECHBio-Techne CorporationSep 2026-$71.2M -10.6%—2.7%
AZTAAzenta, Inc.Sep 2026-$77.4M -248.4%—4.5%
BIOBio-Rad Laboratories, Inc.Jun 2026-$271.3M -76.1%—2.6%
Peer median (excluding MRVI) -$16.04M-141.1%—0.5%

Competitors are the stored peer set for MRVI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents551.27M632.14M574.96M322.4M216.89M
Short-term Investments00000
Net Receivables117.51M146.81M55.72M38.52M25.5M
Inventory51.56M43.15M51.4M50.08M40.5M
Other Current Assets025.8M17.83M18.15M13.37M
Total Current Assets740.04M847.9M699.91M429.15M296.25M
Property, Plant & Equipment (Net)95.43M116.59M222.65M217.03M1.22M
Goodwill152.77M283.67M326.03M159.88M129.43M
Intangible Assets117.57M216.66M220.99M194.96M151.54M
Long-term Investments011.36M8.56M00
Tax Assets808.12M765.8M000
Other Non-current Assets4.36M40.33M9.32M7.24M192.14M
Total Non-current Assets1.18B1.43B787.54M579.1M474.33M
Total Assets1.92B2.28B1.49B1.01B770.58M
Account Payables8.15M5.99M10.73M11.96M0
Short-term Debt6M5.44M5.44M5.44M5.44M
Tax Payables1.4M1.03M1M779K24.49M
Deferred Revenue12.64M3.09M3.36M3.29M0
Other Current Liabilities18.89M69.48M47.62M18.71M39.48M
Total Current Liabilities93.78M110.14M87.47M56.97M44.92M
Long-term Debt524.59M522M518.71M290.49M30.14M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities713.64M693.38M11.98M11.09M322.81M
Total Non-current Liabilities1.28B1.27B610.1M374.06M352.95M
Total Liabilities1.37B1.38B697.57M431.04M397.87M
Common Stock2.55M2.55M2.51M2.53M2.56M
Retained Earnings184.56M404.77M285.74M140.89M10.12M
Accumulated OCI0000524K
Other Stockholders Equity00000
Minority Interest229.86M360.03M373.13M251.92M160.33M
Total Equity545.36M905.24M789.88M577.21M372.71M
Total Debt575.22M585.26M610.97M376.69M35.58M
Net Debt23.95M(46.88M)36.01M54.29M(181.31M)

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

Intrinsic Alpha fair value

Locked

Current Price

$7.38

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.